A study for a 57 year old man who takes Sandostatin Lar - from FDA reports


1,557 males aged 57 (±5) who take the same drug are studied. This is a personalized study for a 57 year old male patient who has Metastatic Carcinoid Tumor. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Jul, 16, 2018

1,557 males aged 57 (±5) who take Sandostatin Lar are studied.


Number of reports submitted per year:

Sandostatin Lar for a 57-year old man.

Information of the patient in this study:

  • Age: 57
  • Gender: male
  • Conditions: Metastatic Carcinoid Tumor
  • Drugs taken:
    • Sandostatin Lar (octreotide acetate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Skin Nodule(slightly elevated lesions on or in the skin): 0 (0% of males aged 57 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  1. High blood pressure
  2. Diarrhea
  3. Injection site pain
  4. Weight decreased
  5. Body temperature decreased
1 - 6 months:
  1. Death
  2. Diarrhea
  3. Nausea (feeling of having an urge to vomit)
  4. Fatigue (feeling of tiredness)
  5. High blood pressure
6 - 12 months:
  1. Death
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Weakness
  4. Abdominal pain
  5. Malignant neoplasm progression (cancer tumour came back)
1 - 2 years:
  1. Death
  2. Fatigue (feeling of tiredness)
  3. Weight decreased
  4. Blood pressure systolic increased
  5. Weakness
2 - 5 years:
  1. Abdominal pain
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Weakness
  5. Hypotension (abnormally low blood pressure)
5 - 10 years:
  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Weight decreased
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Peripheral swelling
  5. Diarrhea
10+ years:
  1. Weakness
  2. Drug ineffective
  3. Headache (pain in head)
  4. Abdominal pain
  5. Gynaecomastia (enlargement of the gland tissue of the male breast)
not specified:
  1. Diarrhea
  2. Nausea (feeling of having an urge to vomit)
  3. High blood pressure
  4. Fatigue (feeling of tiredness)
  5. Abdominal pain

Top conditions involved for these people *:

  1. Carcinoid Tumor : 243 people, 15.61%
  2. Neuroendocrine Tumor : 224 people, 14.39%
  3. Pancreatic Neuroendocrine Tumor : 83 people, 5.33%
  4. High Blood Pressure : 57 people, 3.66%
  5. Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 56 people, 3.60%

Top co-used drugs for these people *:

  1. Afinitor (108 people, 6.94%)
  2. Prilosec (49 people, 3.15%)
  3. Omeprazole (45 people, 2.89%)
  4. Lasix (44 people, 2.83%)
  5. Zofran (43 people, 2.76%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:



Related studies:

Related publications that referenced our studies

Recent updates

General studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.